29 种非处方药商用兽用大麻补充剂的大麻素、萜烯和重金属分析。

IF 1.7 Q2 VETERINARY SCIENCES Veterinary medicine (Auckland, N.Z.) Pub Date : 2020-04-15 eCollection Date: 2020-01-01 DOI:10.2147/VMRR.S248712
Joseph J Wakshlag, Stephen Cital, Scott J Eaton, Reece Prussin, Christopher Hudalla
{"title":"29 种非处方药商用兽用大麻补充剂的大麻素、萜烯和重金属分析。","authors":"Joseph J Wakshlag, Stephen Cital, Scott J Eaton, Reece Prussin, Christopher Hudalla","doi":"10.2147/VMRR.S248712","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The use of veterinary low tetrahydrocannabinol (THC) <i>Cannabis sativa</i> (ie, hemp) products has increased in popularity for a variety of pet ailments. Low-THC <i>Cannabis sativa</i> is federally legal for sale and distribution in the USA, and the rise in internet commerce has provided access to interested consumers, with minimal quality control.</p><p><strong>Materials and methods: </strong>We performed an internet word search of \"hemp extract and dog\" or \"CBD product and dog\" and analyzed 29 products that were using low-THC <i>Cannabis sativa</i> extracts in their production of supplements. All products were tested for major cannabinoids including cannabidiol (CBD), ∆9-tetrahydrocannabinol (THC), cannabigerol (CBG), and other minor cannabinoids, as well as their carboxylic acid derivatives (CBDA, THCA, CBGA) using an ISO/IEC 17025 certified laboratory. Products were also tested for major terpenes and heavy metals to understand constituents in the hemp plants being extracted and distributed.</p><p><strong>Results: </strong>All products were below the federal limit of 0.3% THC with variable amounts of CBD (0-88 mg/mL or g). Only two products did not supply a CBD or total cannabinoid concentration on their packaging or website, while 22/29 could supply a certificate of analysis (COA) from a third-party laboratory. Ten of the 27 products were within 10% of the total cannabinoid concentrations of their label claim with a median concentration of 93% of claims (0-154%). Heavy metal contamination was found in 4/29 products, with lead being the most prevalent contaminant (3/29).</p><p><strong>Conclusion: </strong>The products analyzed had highly variable concentrations of CBD or total cannabinoids with only 18 of 29 being appropriately labeled according to current FDA non-medication, non-dietary supplement or non-food guidelines. Owners and veterinarians wanting to utilize CBD-rich <i>Cannabis sativa</i> products should be aware of low-concentration products and should obtain a COA enabling them to fully discuss the implications of use and calculated dosing before administering to pets.</p>","PeriodicalId":75300,"journal":{"name":"Veterinary medicine (Auckland, N.Z.)","volume":"11 ","pages":"45-55"},"PeriodicalIF":1.7000,"publicationDate":"2020-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/31/vmrr-11-45.PMC7169471.pdf","citationCount":"0","resultStr":"{\"title\":\"Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements.\",\"authors\":\"Joseph J Wakshlag, Stephen Cital, Scott J Eaton, Reece Prussin, Christopher Hudalla\",\"doi\":\"10.2147/VMRR.S248712\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The use of veterinary low tetrahydrocannabinol (THC) <i>Cannabis sativa</i> (ie, hemp) products has increased in popularity for a variety of pet ailments. Low-THC <i>Cannabis sativa</i> is federally legal for sale and distribution in the USA, and the rise in internet commerce has provided access to interested consumers, with minimal quality control.</p><p><strong>Materials and methods: </strong>We performed an internet word search of \\\"hemp extract and dog\\\" or \\\"CBD product and dog\\\" and analyzed 29 products that were using low-THC <i>Cannabis sativa</i> extracts in their production of supplements. All products were tested for major cannabinoids including cannabidiol (CBD), ∆9-tetrahydrocannabinol (THC), cannabigerol (CBG), and other minor cannabinoids, as well as their carboxylic acid derivatives (CBDA, THCA, CBGA) using an ISO/IEC 17025 certified laboratory. Products were also tested for major terpenes and heavy metals to understand constituents in the hemp plants being extracted and distributed.</p><p><strong>Results: </strong>All products were below the federal limit of 0.3% THC with variable amounts of CBD (0-88 mg/mL or g). Only two products did not supply a CBD or total cannabinoid concentration on their packaging or website, while 22/29 could supply a certificate of analysis (COA) from a third-party laboratory. Ten of the 27 products were within 10% of the total cannabinoid concentrations of their label claim with a median concentration of 93% of claims (0-154%). Heavy metal contamination was found in 4/29 products, with lead being the most prevalent contaminant (3/29).</p><p><strong>Conclusion: </strong>The products analyzed had highly variable concentrations of CBD or total cannabinoids with only 18 of 29 being appropriately labeled according to current FDA non-medication, non-dietary supplement or non-food guidelines. Owners and veterinarians wanting to utilize CBD-rich <i>Cannabis sativa</i> products should be aware of low-concentration products and should obtain a COA enabling them to fully discuss the implications of use and calculated dosing before administering to pets.</p>\",\"PeriodicalId\":75300,\"journal\":{\"name\":\"Veterinary medicine (Auckland, N.Z.)\",\"volume\":\"11 \",\"pages\":\"45-55\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2020-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/31/vmrr-11-45.PMC7169471.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Veterinary medicine (Auckland, N.Z.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/VMRR.S248712\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"VETERINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary medicine (Auckland, N.Z.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/VMRR.S248712","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

目的:兽用低四氢大麻酚(THC)大麻(即大麻)产品越来越多地用于治疗各种宠物疾病。在美国,低四氢大麻酚大麻的销售和分销是合法的,互联网商业的兴起为感兴趣的消费者提供了渠道,但质量控制却微乎其微:我们在互联网上搜索了 "大麻提取物和狗 "或 "CBD 产品和狗",并分析了 29 种使用低 THC 籽大麻提取物生产保健品的产品。使用 ISO/IEC 17025 认证实验室对所有产品进行了主要大麻素(包括大麻二酚 (CBD)、∆9-四氢大麻酚 (THC)、大麻萜醇 (CBG))和其他次要大麻素及其羧酸衍生物(CBDA、THCA、CBGA)的检测。此外,还对产品进行了主要萜烯和重金属检测,以了解提取和分销的大麻植物中的成分:结果:所有产品的四氢大麻酚含量均低于 0.3% 的联邦限值,而 CBD 含量则各不相同(0-88 mg/mL 或 g)。只有两种产品没有在其包装或网站上提供 CBD 或大麻素总浓度,而 22/29 种产品可以提供第三方实验室的分析证书(COA)。在 27 种产品中,有 10 种产品的大麻素总浓度不超过其标签标称浓度的 10%,中位浓度为标称浓度的 93%(0-154%)。在 4/29 种产品中发现了重金属污染,其中铅是最常见的污染物(3/29):分析的产品中 CBD 或总大麻素的浓度差异很大,29 种产品中只有 18 种按照美国食品及药物管理局(FDA)现行的非药物、非膳食补充剂或非食品指南进行了适当标注。希望使用富含 CBD 的大麻产品的主人和兽医应该了解低浓度产品,并应获得 COA,以便在给宠物用药前充分讨论使用和计算剂量的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements.

Purpose: The use of veterinary low tetrahydrocannabinol (THC) Cannabis sativa (ie, hemp) products has increased in popularity for a variety of pet ailments. Low-THC Cannabis sativa is federally legal for sale and distribution in the USA, and the rise in internet commerce has provided access to interested consumers, with minimal quality control.

Materials and methods: We performed an internet word search of "hemp extract and dog" or "CBD product and dog" and analyzed 29 products that were using low-THC Cannabis sativa extracts in their production of supplements. All products were tested for major cannabinoids including cannabidiol (CBD), ∆9-tetrahydrocannabinol (THC), cannabigerol (CBG), and other minor cannabinoids, as well as their carboxylic acid derivatives (CBDA, THCA, CBGA) using an ISO/IEC 17025 certified laboratory. Products were also tested for major terpenes and heavy metals to understand constituents in the hemp plants being extracted and distributed.

Results: All products were below the federal limit of 0.3% THC with variable amounts of CBD (0-88 mg/mL or g). Only two products did not supply a CBD or total cannabinoid concentration on their packaging or website, while 22/29 could supply a certificate of analysis (COA) from a third-party laboratory. Ten of the 27 products were within 10% of the total cannabinoid concentrations of their label claim with a median concentration of 93% of claims (0-154%). Heavy metal contamination was found in 4/29 products, with lead being the most prevalent contaminant (3/29).

Conclusion: The products analyzed had highly variable concentrations of CBD or total cannabinoids with only 18 of 29 being appropriately labeled according to current FDA non-medication, non-dietary supplement or non-food guidelines. Owners and veterinarians wanting to utilize CBD-rich Cannabis sativa products should be aware of low-concentration products and should obtain a COA enabling them to fully discuss the implications of use and calculated dosing before administering to pets.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
16 weeks
期刊最新文献
Incidence of Chlamydia spp., FIV, FeLV in Free-Roaming Cats in Slovakia. Validation of Noninvasive Methemoglobin and Carboxyhemoglobin Measurements Using Pulse Co-Oximeter in Healthy Dogs. Fecal Microbiota Transplantation in a Domestic Ferret Suffering from Chronic Diarrhea and Maldigestion-Fecal Microbiota and Clinical Outcome: A Case Report. Extended-Spectrum Beta-Lactamase Producing Escherichia coli in Raw Cow Milk At Selling Points and Determinants of Contamination in and Around Chencha, Southern Ethiopia. Molecular Detection and Serological Investigation of Newcastle Disease in Intensive, Semi-Intensive, and Backyard Production Systems in Central and Southwestern Areas of Ethiopia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1